Clinical Trial Update: Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer [NA]

View source ↗

Summary

Clinical trial NCT05876065 is evaluating a capecitabine and cyclophosphamide (XC) maintenance regimen for advanced breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Capecitabine (capecitabine)

Snippet

Sponsor: Wenjin Yin | Conditions: Advanced Breast Cancer | NA | Status: RECRUITING